Advertisement

Advertisement

LGVN Stock Latest News

Longeveron granted SME status by European Medicines Agency

The FlyLongeveron granted SME status by European Medicines Agency

Longeveron Announces CFO Transition to Internal Successor

PremiumCompany Announcements

Longeveron Announces CFO Transition to Internal Successor

9d ago

Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles

PremiumCompany Announcements

Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles

1M ago

Longeveron reports Q1 EPS (19c) vs. (34c) last year

PremiumThe Fly

Longeveron reports Q1 EPS (19c) vs. (34c) last year

1M ago

Longeveron reports DMC approval for laromestrocel study to continue as designed

PremiumThe Fly

Longeveron reports DMC approval for laromestrocel study to continue as designed

1M ago

Longeveron downgraded to Hold from Buy at Maxim

PremiumThe FlyLongeveron downgraded to Hold from Buy at Maxim

1M ago

Is LGVN a Buy, Before Earnings?

Pre-Earnings

Is LGVN a Buy, Before Earnings?

1M ago

Longeveron provides update on laromestrocel development after Type C meeting

The Fly

Longeveron provides update on laromestrocel development after Type C meeting

1M ago

Longeveron Updates FDA Path for ELPIS II Trial

PremiumCompany Announcements

Longeveron Updates FDA Path for ELPIS II Trial

1M ago

Longeveron price target lowered to $8 from $10 at H.C. Wainwright

PremiumThe Fly

Longeveron price target lowered to $8 from $10 at H.C. Wainwright

1M ago

Longeveron Restores Executive Pay After Recent Financing

PremiumCompany Announcements

Longeveron Restores Executive Pay After Recent Financing

2M ago

Longeveron files to sell 30.87M shares of Class A common stock for holders

PremiumThe Fly

Longeveron files to sell 30.87M shares of Class A common stock for holders

2M ago

Longeveron granted Chinese patent for potency assay methods

PremiumThe FlyLongeveron granted Chinese patent for potency assay methods

2M ago

Longeveron granted Chinese patent for potency assay methods

The Fly

Longeveron granted Chinese patent for potency assay methods

2M ago

Longeveron Receives Extended Nasdaq Compliance Grace Period

Company Announcements

Longeveron Receives Extended Nasdaq Compliance Grace Period

3M ago

Longeveron Cancels Special Meeting, Reschedules Reverse Split Vote

PremiumCompany Announcements

Longeveron Cancels Special Meeting, Reschedules Reverse Split Vote

3M ago

Longeveron’s Alzheimer’s Program Faces High Late-Stage Failure Risk and Potential Pipeline Pressure

PremiumCompany Announcements

Longeveron’s Alzheimer’s Program Faces High Late-Stage Failure Risk and Potential Pipeline Pressure

3M ago

Longeveron Earnings Call: Pivotal Trials, Tight Cash

PremiumCompany Announcements

Longeveron Earnings Call: Pivotal Trials, Tight Cash

3M ago

Longeveron price target lowered to $2 from $3 at Roth Capital

PremiumThe Fly

Longeveron price target lowered to $2 from $3 at Roth Capital

3M ago

Longeveron Announces $30 Million Private Placement Financing

PremiumCompany AnnouncementsLongeveron Announces $30 Million Private Placement Financing

3M ago

3 Penny Stocks to Watch Now, 3/11/26

Market News

3 Penny Stocks to Watch Now, 3/11/26

3M ago

Longeveron prices 6.01M shares at 52c in private placement

The Fly

Longeveron prices 6.01M shares at 52c in private placement

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >